Antihistamine Therapy for Mild Rash

First-Line Antihistamine Options

The American College of Dermatology recommends loratadine 10 mg daily as the first choice for systemic therapy during daytime hours 1, 2
Cetirizine is an alternative second-generation option with the shortest time to maximum concentration, which may be advantageous when rapid availability is needed 3
Fexofenadine is another non-sedating option that can be considered 3
Desloratadine has the longest elimination half-life at 27 hours 3
Diphenhydramine 25-50 mg daily may be considered based on sedative properties for patients with nighttime pruritus 1, 2
Hydroxyzine 25-50 mg daily is another first-generation option for nighttime use 1, 2

For mild or localized rash, continue any causative medication at current dose and monitor for severity changes, and apply topical moderate/high-potency steroids (such as mometasone furoate 0.1% or betamethasone valerate 0.1% ointment) 1, 2
Add oral antihistamines as outlined above for symptomatic relief 1, 2
Reassess after 2 weeks; if reactions worsen or do not improve, escalate therapy 1, 2

Topical steroids should be used concurrently with oral antihistamines for optimal management 1, 2
In patients with renal impairment, cetirizine and hydroxyzine doses should be halved in moderate renal impairment; avoid in severe impairment 3
In patients with hepatic impairment, avoid hydroxyzine and chlorphenamine in severe liver disease due to inappropriate sedation 3
In pregnancy, avoid all antihistamines when possible, especially first trimester; chlorphenamine often chosen when necessary due to safety record 3
In children, consult product-specific data sheets for age restrictions and dosing 3
Offer patients a choice of at least two non-sedating H1 antihistamines, as responses and tolerance vary between individuals 3